xanomeline-trospium (karxt) shows efficacy in phase 3 trial for schizophrenia
Published 2 months ago • 1.7K plays • Length 8:16Download video MP4
Download video MP3
Similar videos
-
1:50
clinical trial: xanomeline and trospium chloride capsules for schizophrenia (nct04659174)
-
4:47
schizophrenia treatment revolution? introducing xanomeline: potential and latest updates
-
10:33
karuna therapeutics - trial evaluating karxt in schizophrenia
-
12:40
karuna therapeutics - follow-up on trial evaluating karxt in schizophrenia
-
8:28
new medication monday: kar-xt xanomeline and trospium combination
-
10:33
karuna therapeutics - trial evaluating karxt in schizophrenia
-
25:52
treating schizophrenia with muscarinic antipsychotics | steve paul
-
8:08
karxt for schizophrenia: mechanism of action?
-
9:14
antipsychotic plasma levels and adherence
-
10:22
phase 2 trial results for novel treatment of adults with schizophrenia
-
7:12
muscarinic cholinergic m1/m4 stimulation: muscarinic agents for scz treatment
-
10:56
lumateperone for the treatment of schizophrenia
-
13:33
psychopharm in 2019: your ultimate guide
-
0:36
dr. caron - are there new medications for schizophrenia in the works?
-
1:59
carbamazepine | psychopharmacology review
-
8:18
new and novel schizophrenia treatment paradigms: moving beyond post-synaptic dopamine modulation